Literature DB >> 17487556

Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Shibu Thomas1, Maurizio Chiriva-Internati, Girish V Shah.   

Abstract

Abundance of calcitonin (CT) and calcitonin receptor (CTR) mRNA in primary prostate tumors positively correlates with tumor grade, and exogenously added CT increases the invasion of prostate cancer cell lines. We examined acute and chronic actions of CT on migration of highly metastatic PC-3M cells and poorly invasive LNCaP cells on several extracellular matrices in a spheroid disaggregation/migration assay. While PC-3M spheroids displayed maximum disaggregation/migration on vitronectin (VN), LNCaP spheroids preferred collagen but also migrated significantly on VN. Up-regulation of CT significantly enhanced disaggregation/migration of PC-3M spheroids on VN, but not on fibronectin. In contrast, down-regulation of CT, CTR, protein kinase A or urokinase-type plasminogen activator receptor (uPAR) led to amelioration of PC-3M spheroid disaggregation/migration. CT selectively increased surface activity of alpha v beta 3 or alpha 6 beta 5 integrins in PC-3M and LNCaP cell lines, respectively, and uPAR-integrin association. Finally, either CT or urokinase could completely restore migration of CT-knock-down PC-3M spheroids. But, only forced expression of urokinase receptor coupled with exogenous addition of urokinase restored migration of CTR-knock-down spheroids. These results support our hypothesis that up-regulation of CT biosynthesis and activation of CT-CTR axis in primary prostate tumors may have direct relevance in their progression to the metastatic phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487556     DOI: 10.1007/s10585-007-9073-y

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  58 in total

1.  Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.

Authors:  M Sumitomo; R Shen; M Walburg; J Dai; Y Geng; D Navarro; G Boileau; C N Papandreou; F G Giancotti; B Knudsen; D M Nanus
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

2.  Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells.

Authors:  Srinivasulu Chigurupati; Trupti Kulkarni; Shibu Thomas; Girish Shah
Journal:  Cancer Res       Date:  2005-09-15       Impact factor: 12.701

3.  Calcitonin inhibits prolactin promoter activity in rat pituitary GGH3 cells: evidence for involvement of p42/44 mitogen-activated protein kinase in calcitonin action.

Authors:  Yuan Ren; Ya-Ping Sun; Girish V Shah
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

4.  Changes in cell proliferation and apoptosis during local progression of prostate cancer.

Authors:  T Kaibuchi; Y Furuya; K Akakura; M Masai; H Ito
Journal:  Anticancer Res       Date:  2000 Mar-Apr       Impact factor: 2.480

5.  RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.

Authors:  Sai MuraliKrishna Pulukuri; Christopher S Gondi; Sajani S Lakka; Aman Jutla; Norman Estes; Meena Gujrati; Jasti S Rao
Journal:  J Biol Chem       Date:  2005-08-26       Impact factor: 5.157

6.  Regulation and activation of focal adhesion kinase and paxillin during the adhesion, proliferation, and differentiation of prostatic epithelial cells in vitro and in vivo.

Authors:  L Tremblay; W Hauck; L T Nguyen; P Allard; F Landry; A Chapdelaine; S Chevalier
Journal:  Mol Endocrinol       Date:  1996-08

7.  A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth.

Authors:  K K Wary; A Mariotti; C Zurzolo; F G Giancotti
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

8.  Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells.

Authors:  O Nagakawa; M Ogasawara; H Fujii; K Murakami; J Murata; H Fuse; I Saiki
Journal:  Cancer Lett       Date:  1998-11-13       Impact factor: 8.679

9.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence.

Authors:  W D Tilley; G Buchanan; T E Hickey; J M Bentel
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

10.  Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.

Authors:  Jeffrey A Nemeth; Michael L Cher; Zhao Zhou; Chadwick Mullins; Sunita Bhagat; Mohit Trikha
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  8 in total

1.  Role of integrins in regulating proteases to mediate extracellular matrix remodeling.

Authors:  Jiao Yue; Kun Zhang; Jianfeng Chen
Journal:  Cancer Microenviron       Date:  2012-03-22

2.  A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.

Authors:  Arvind Thakkar; Ahmed Aljameeli; Shibu Thomas; Girish V Shah
Journal:  Endocr Relat Cancer       Date:  2015-10-02       Impact factor: 5.678

3.  Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/β-catenin signaling is enhanced in irradiated medulloblastoma cells.

Authors:  Swapna Asuthkar; Christopher S Gondi; Arun Kumar Nalla; Kiran Kumar Velpula; Bharathi Gorantla; Jasti S Rao
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

4.  PROL1 is essential for xenograft tumor development in mice injected with the human prostate cancer cell-line, LNCaP, and modulates cell migration and invasion.

Authors:  Amarnath Mukherjee; Augene Park; Kelvin Paul Davies
Journal:  J Mens Health       Date:  2021-10-14       Impact factor: 0.789

5.  Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.

Authors:  Khalid A El Sayed; Mohammad A Khanfar; Hassan M Shallal; A Muralidharan; Bhushan Awate; Diaa T A Youssef; Yang Liu; Yu-Dong Zhou; Dale G Nagle; Girish Shah
Journal:  J Nat Prod       Date:  2008-02-26       Impact factor: 4.050

6.  Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis.

Authors:  Girish V Shah; Anbalagan Muralidharan; Shibu Thomas; Mitan Gokulgandhi; Mudit Mudit; Mohammad Khanfar; Khalid El Sayed
Journal:  Mol Cancer Ther       Date:  2009-03-10       Impact factor: 6.261

7.  Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.

Authors:  Maria Rita Milone; Biagio Pucci; Katia Bifulco; Federica Iannelli; Rita Lombardi; Chiara Ciardiello; Francesca Bruzzese; Maria Vincenza Carriero; Alfredo Budillon
Journal:  Oncotarget       Date:  2015-03-10

8.  RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Authors:  Mark Sutherland; Andrew Gordon; Steven D Shnyder; Laurence H Patterson; Helen M Sheldrake
Journal:  Cancers (Basel)       Date:  2012-10-26       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.